| Authors: |
Gil-Rojas Y; Neuroeconomix, Bogotá, Bogotá DC, Colombia., Lasalvia P; Neuroeconomix, Bogotá, Bogotá DC, Colombia., Sáenz V; Virrey Solís IPS, Bogotá, Bogotá DC, Colombia., Virgüez O; Virrey Solís IPS, Bogotá, Bogotá DC, Colombia., Peña MP; Neuroeconomix, Bogotá, Bogotá DC, Colombia., Castañeda-Cardona C; Neuroeconomix, Bogotá, Bogotá DC, Colombia., Laucho-Contreras ME; Regional Medical, GlaxoSmithKline, Bogotá, Bogotá DC, Colombia., González AL; Health Outcomes, GlaxoSmithKline, Bogotá, Bogotá DC, Colombia. Electronic address: andres.l.gonzalez@gsk.com., García-Nuncira CY; Value and Access, GlaxoSmithKline, Bogotá, Bogotá DC, Colombia., Rosselli D; Clinical Epidemiology and Biostatistics Department, Pontificia Universidad Javeriana, Bogotá, Bogotá DC, Colombia. |